translation agency

NLM AIDSLINE
Differential in vitro anti-HIV activity of natural lignans.
Schroder HC; Merz H; Steffen R; Muller WE; Sarin PS; Trumm S; Schulz J;
September 30, 1991
Z Naturforsch [C]. 1990 Nov-Dec;45(11-12):1215-21. Unique Identifier :

Two naturally occurring lignanolides, isolated from the tropical climbing shrub Ipomoea cairica, (-)-arctigenin and (-)-trachelogenin, were found to inhibit strongly replication of human immunodeficiency virus type 1 (HIV-1; strain HTLV-III B) in vitro. At a concentration of 0.5 microM, (-)-arctigenin and (-)-trachelogenin inhibited the expression of HIV-1 proteins p17 and p24 by 80-90% and 60-70%, respectively. The reverse transcriptase activity in the culture fluids was reduced by 80-90% when the cells (HTLV-III B/H9) were cultivated in the presence of 0.5 microM (-)-arctigenin or 1 microM (-)-trachelogenin. At the same concentrations, the formation of syncytia in the HTLV-III B/H9-Jurkat cell system was inhibited by the compounds by more than 80%. A series of other lignan type compounds displayed no anti-HIV activity. Studying the molecular mechanism of action of (-)-arctigenin and (-)-trachelogenin we found that both compounds are efficient inhibitors of the nuclear matrix-associated DNA topoisomerase II activity, particularly of the enzyme from HIV-1-infected cells. Our results suggest that both compounds prevent the increase of topoisomerase II activity, involved in virus replication, after infection of cells with HIV-1.

Animal Antiviral Agents/*PHARMACOLOGY Cell Division/DRUG EFFECTS Cell Line Comparative Study DNA Topoisomerase (ATP-Hydrolysing)/METABOLISM Human HIV/*DRUG EFFECTS/PHYSIOLOGY HIV-1/*DRUG EFFECTS/PHYSIOLOGY Leukemia L5178 Lignin/*PHARMACOLOGY Mice Plasmids Structure-Activity Relationship Support, Non-U.S. Gov't Viral Proteins/BIOSYNTHESIS JOURNAL ARTICLE

www.aegis.org